Exit Strategy
Investor Returns
A clear path to liquidity with multiple exit options and strong projected returns.
85% occupancy
Project IRR
74%
5-year internal rate of return
5-Year MOIC
6.7x
Multiple on invested capital
Total Investment
$13.8M
All-equity structure
Est. Exit Value
$87.9M
5.5x EBITDA + retained cash
Return Timeline
Year 1
$5.1M
Net Income
Year 2
$6.9M
Net Income
Year 3
$7.3M
Net Income
Year 4
$7.2M
Net Income
Year 5
$7.0M
Net Income
Exit Pathways
Strategic Sale
Year 5-7
Sale to hospitality group, healthcare system, or wellness conglomerate seeking turnkey medical retreat operations.
Multiple
8-10x EBITDA
Private Equity
Year 4-6
Acquisition by PE firm building a platform in the wellness or alternative healthcare space.
Multiple
7-9x EBITDA
Management Buyout
Year 5+
Existing management team acquires equity stake, often with seller financing component.
Multiple
6-8x EBITDA
Return by Scenario
| Metric | Conservative | Base | Aggressive |
|---|---|---|---|
| 5-Year Total Revenue | $61.9M | $82.1M | $88.7M |
| Project IRR | 66.5% | 73.5% | 80.1% |
| 5-Year MOIC | 4.7x | 6.7x | 8.9x |
| Est. Enterprise Value (Y5) | $62.0M | $87.9M | $117.6M |
Value Creation Drivers
Revenue Growth
+24% Y1-Y5 growthRevenue growth driven by phased capacity expansion from 16 to 30 rooms and increasing occupancy.
Margin Expansion
+11pp margin expansionEBITDA margin improvement from 45% in Year 1 to 55% at full capacity through operational leverage.
Brand Premium
8-10x EBITDA at exitBuilding category-leading brand equity in medical-grade psychedelic therapy commands premium multiples.
Expansion Optionality
Platform premiumProven playbook enables multi-location expansion, creating platform value for strategic acquirers.
Investment Summary
A compelling risk-adjusted opportunity in a rapidly growing market with multiple paths to attractive returns.
Projected Return
6.7x
on invested capital